I  PureTech Ventures


     Office Locations:

500 Boylston Street, Suite 1600
Boston, MA 02116
Phone: 617-482-2333
Fax: 617-482-3337



  • Early
  • Seed



  • Life Sciences & Healthcare
  • Medical Device



    PureTech is committed to creating innovative life sciences companies. Neither a venture fund or an incubator, PureTech proactively forms companies and drives them forward as the primary founder. PureTech transforms breakthrough technologies into organizations that tackle major unmet needs that have yet to be addressed by emerging science. The firm specializes in seed and early-stage investment in novel therapeutics, medical devices, and platform technologies. The firm encourages scientists and entrepreneurs to contact them at the idea stage, before a company is formed or a business plan has been written. PureTech was founded by a group of entrepreneurs and pharmaceutical industry executives to bridge the 'venture gap' between the lab and venture capital.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Christopher Viehbacher Senior Partner
    Daphne Zohar Founder & Managing Partner
    David Steinberg Executive Vice President & Partner
    Dr. Andrew Miller Vice President & Principal
    Dr. Bennett Shapiro Co-Founder, Board Member & Senior Partner


    Recent Funding Events (trailing 12 months):







      Karuna Pharmaceuticals



      Series A


    Portfolio companies include:

      Akili Interactive Labs
        web link

        web link

        web link

      Enlight Biosciences
        web link

        web link

        web link

        web link

        web link

      Karuna Pharmaceuticals
        web link

        web link

      Libra Biosciences
        web link

      Mandara Sciences
        web link

        web link

        web link

      Protein Forest
        web link

        web link

      Satori Pharmaceuticals
        web link

      Tal Medical
        web link

      Vascular Biogenics
        web link

      Vedanta Biosciences
        web link

      Vendanta Biosciences
        web link

        web link


    Recent News:

      There is no recent news for PureTech Ventures.